The Florida Hospital - Sanford Burnham Prebys Translational Research Institute for Metabolism and Diabetes (TRI-MD) is a collaboration that serves as a bridge between basic discovery research and patient-oriented research. The TRI-MD is expected to hasten the discovery and development of new approaches to diagnose, prevent, and treat diabetes, obesity and their cardiovascular complications. One key aim is to produce unique insights into the sub-classifications of diabetes, thus promoting the advent of personalized disease therapies.
In 2006, Sanford Burnham Prebys Medical Discovery Institute initiated plans for a research facility in Orlando, Florida, and began discussions with regional life science organizations about collaborative opportunities. Florida Hospital, one of the largest not-for-profit hospital systems in the country, became an early partner of SBP with complementary clinical expertise in metabolism and an established clinical diabetes research program. In 2008, the Florida Hospital - SBP TRI was formed to facilitate the translation of novel scientific discoveries into practical therapeutic applications for diabetes and obesity.